A real-life study of daratumumab combinations in newly diagnosed patients with light chain (AL) amyloidosis.
Bellofiore C, Benvenuti P, Mina R, Basset M, Foli A, Nanci M, Nuvolone M, Guida G, Attanasio A, Mussinelli R, Mangiacavalli S, Cartia CS, Masoni V, Palumbo M, Cani L, Oliva S, Consoli U, Conticello C, Di Raimondo F, Arcaini L, Bringhen S, Merlini G, Palladini G, Milani P.
Bellofiore C, et al.
Hematol Oncol. 2024 Jul;42(4):e3289. doi: 10.1002/hon.3289.
Hematol Oncol. 2024.
PMID: 38824453